Beyond Blood Pressure
- 1 February 2005
- journal article
- Published by Wolters Kluwer Health in Hypertension
- Vol. 45 (2) , 185-186
- https://doi.org/10.1161/01.hyp.0000154086.58818.5a
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Angiotensin II Type-1 Receptor Antagonism Attenuates the Inflammatory and Thrombogenic Responses to Hypercholesterolemia in VenulesHypertension, 2005
- Hypertension mega-trials with cardiovascular end points: Effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockersAmerican Heart Journal, 2004
- Mortality and Morbidity Reduction With Candesartan in Patients With Chronic Heart Failure and Left Ventricular Systolic DysfunctionCirculation, 2004
- Therapeutic approaches in the prevention of cardiovascular disease in metabolic syndrome and in patients with type 2 diabetesCurrent Opinion in Cardiology, 2004
- Direct evidence of leukocyte adhesion in arterioles by angiotensin IIBlood, 2004
- Comparative effects of AT1-antagonism and angiotensin-converting enzyme inhibition on markers of inflammation and platelet aggregation in patients with coronary artery diseaseJournal of the American College of Cardiology, 2004
- Modulation of the Inflammatory Response in Cardiovascular DiseaseHypertension, 2004
- NADPH Oxidase in Endothelial Cells: Impact on AtherosclerosisAntioxidants and Redox Signaling, 2003
- Dose-Dependent Regulation of NAD(P)H Oxidase Expression by Angiotensin II in Human Endothelial CellsArteriosclerosis, Thrombosis, and Vascular Biology, 2002
- Upregulation of LOX-1 Expression in Aorta of Hypercholesterolemic Rabbits: Modulation by LosartanBiochemical and Biophysical Research Communications, 2000